A 52-year-old woman presented to the ENT clinic with a huge swelling on the right side of her face that had originated 6 years earlier. The mass was ultimately diagnosed as a carcinoma ex pleomorphic adenoma of the maxillary sinus. Carcinoma ex pleomorphic adenoma itself is uncommon, and its origin in the maxillary sinus is very rare. We discuss the presentation, histopathologic picture, and management of this case.
Introduction
Carcinoma ex pleomorphic adenoma is a malignant epithelial salivary gland neoplasm that arises from or within a pleomorphic adenoma. It accounts for 2 to 4% of all salivary gland neoplasms. 1 It is seen primarily in the parotid glands; rarely is it seen in the minor salivary glands. Pleomorphic adenomas of the maxillary sinus are rare, and hence the malignant form at that site is even more rare. Although some cases of carcinoma ex pleomorphic adenoma of the maxillary sinus have been occasionally reported as part of large series, only a few reports in the literature include a detailed discussion of its clinical presentation and radiologic and intraoperative findings.
Case report
A 52-year-old woman presented to us with a large swelling over the right cheek and a loss of vision in the right eye. The swelling had progressed gradually over a period of 6 years, but its rate of growth had accelerated during the 7 months prior to presentation. The patient's history included a similar swelling in the right cheek 20 years earlier that had been removed surgically via an external approach.
On examination, a large bosselated swelling measuring approximately 8 × 10 cm was present on the right cheek (figure 1). The mass extended superiorly to the margin of the lower eyelid, and it completely closed the palpebral fissure. The skin over the swelling was pliable. A faint lateral rhinotomy scar could be discerned on the right side. The swelling was firm to hard in consistency, and its margins were well defined.
On anterior rhinoscopy, the right nasal cavity was completely obliterated, and the septum was pushed to the opposite side. Examination of the oral cavity revealed the presence of a mucosa-covered growth that had eroded through the hard palate posteriorly. Findings on posterior rhinoscopy were normal. The visual acuity of the right eye was reduced to light perception. The left eye was normal. The results of a complete blood panel were within normal limits.
A biopsy was obtained from the oral portion of the mass, and it was reported as a pleomorphic adenoma of the salivary gland. Magnetic resonance imaging (MRI) detected a heterogeneous, minimally enhancing, 7.3 × 6.4-cm mass with internal septations in the right maxilla (figure 2). The mass involved the nasal cavity and ethmoid sinuses medially, and it had infiltrated the orbital floor superiorly, causing an upward displacement of the eyeball; it had also infiltrated the buccinator muscle laterally. The pterygopalatine fossa and pterygoid muscles were normal.
With the diagnosis of pleomorphic adenoma, the patient was taken to the operating room for surgical excision of the tumor. The tumor was exposed via a Weber-Dieffenbach incision. As the tumor was fixed to the surrounding bones, a total maxillectomy was necessary. An obturator was used to close the oral defect, and the incision site was sutured. The patient experienced no postoperative complications.
Histopathology revealed that the tumor was composed of cuboid to columnar cells with vesicular nuclei. Cells were arranged in solid sheets, lobules, and a tubular pattern in a chondromyxoid stroma (figure 3). A few slides showed the malignant tumor lying adjacent to the benign component. It was reported as a carcinoma ex pleomorphic adenoma.
Discussion
Minor salivary gland tumors are common in the oral cavity, hard palate, lip, and buccal mucosa. According to various reports, 50 to 75% are malignant in nature. 1 Among all minor salivary gland tumors, the most common benign tumor is pleomorphic adenoma. 1 In descending order of frequency, the malignant tumors include adenocystic carcinoma, mucoepidermoid carcinoma, and adenocarcinoma; carcinoma ex pleomorphic adenoma is the sixth most common malignancy. 1 The development of a carcinoma ex pleomorphic adenoma in the sinonasal passage is distinctly unusual. In a study of 492 tumors of minor salivary gland origin, Spiro et al found only a single case of carcinoma ex pleomorphic adenoma that involved the maxillary sinus. 2 Pleomorphic adenomas can undergo a malignant transformation in three different ways:
• Approximately 90% of these malignancies are carcinomas ex pleomorphic adenoma. 3 The incidence of malignancy in pleomorphic adenomas is less than 2% for tumors that have been present for less than 5 years and 10% for those present for more than 15 years. 1 In order to establish a diagnosis of carcinoma ex pleomorphic adenoma, residual histologic evidence of a pleomorphic adenoma must be present. 1 The malignant component is usually an adenocarcinoma associated with infiltrative growth, hemorrhage, necrosis, and cystic change. 1 • The second type of malignancy associated with pleomorphic adenomas is carcinosarcoma, a true malignant mixed tumor. Poorly circumscribed and infiltrative in nature, carcinosarcomas contain both epithelial and mesenchymal components.
• The third type of malignancy is a rare metastasizing mixed tumor with multiple recurrent benign mixed tumors. 1 Pleomorphic adenomas within the maxillary antrum have been known to grow to enormous sizes while involving the surrounding bones and causing mucocele formation. 4 The malignant types can develop in a long-standing benign tumor, and they occasionally take as long as 20 years to become malignant. A rapid onset of growth in a long-standing or recurrent tumor is highly suspicious for malignant change. 5 The treatment of choice is wide surgical excision. 3 Patients with a maxillary tumor may require orbital exenteration in addition to maxillectomy. Postoperative radiotherapy has been shown to significantly improve 5-year local control rates, and it is associated with improved survival among patients who have no evidence of cervical lymph node metastasis. 6 A dosage of 6,000 cGy over 6 weeks is indicated for patients with perineural invasion, positive margins, high-grade histology, neck disease, and recurrence. Also, radiation increases local control in patients with unresectable and inoperable lesions. 7 Postoperative chemotherapy for patients with salivary gland neoplasms is indicated for the presence of recurrent, inoperable, or metastatic disease. Cisplatin, doxorubicin, and 5-fluorouracil have been identified as active agents against mixed malignant tumors. However, the response is partial and may last only 6 to 8 months. 8 Combination chemotherapy that includes docetaxel has shown some promise. 9 While postoperative radiotherapy is advised for all patients, postoperative chemotherapy should be administered judiciously. Although chemotherapy is largely perceived as an adjuvant therapy for palliation in minor salivary gland tumors, it has also been used as a preoperative intra-arterial therapy to shrink tumor size prior to surgery. 8 The prognosis for patients with a minor salivary gland tumor arising in the paranasal sinus is poorer than it is for patients with tumors elsewhere. 2 Reported survival rates for patients with carcinoma ex pleomorphic adenoma are 25 to 65% at 5 years and 10 to 35% at 15 years. 1 Recurrence and metastasis are common. Following the discovery of metastatic disease, death usually follows within 1 year. 1 In conclusion, we emphasize the importance of regular follow-up in all cases of pleomorphic adenoma. The risk of malignant transformation may be only 2 to 10%, 1 but the associated morbidity and mortality are substantial. Our patient exhibited a gross facial deformity that led to a loss of vision on the affected side. This scenario could have been avoided if she had undergone stricter followup after her initial surgery 20 years earlier. 
